Saral Dx (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.49 Cr
- Satisfied Charges ₹ 4.33 Cr
- Revenue Growth 30.30%
- Profit Growth -69.54%
- Ebitda -35.21%
- Net Worth 30.29%
- Total Assets -7.82%
About Saral Dx (Opc)
Saral Dx (Opc) Private Limited (SDOPL) is a Company incorporated in India on 03 June 2021 (Three years and eight months 9 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹14.49 Cr. The company has closed loans amounting to ₹4.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravi Gupta serves as a director at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85300DL2021OPC381847
-
Company No.
381847
-
Incorporation Date
03 Jun 2021
-
Date of AGM
-
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Saral Dx (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Gupta
|
Director | 03-Jun-2021 | Current |
Financial Performance of Saral Dx (Opc).
Saral Dx (Opc) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.3% increase. The company also saw a substantial fall in profitability, with a 69.54% decrease in profit. The company's net worth Soared by an impressive increase of 30.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saral Dx (Opc)?
Unlock access to Saral Dx (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Saral Advanced Diagnostic Private LimitedRavi Gupta is a mutual person
-
Saral Diagnostics Classic Private LimitedRavi Gupta is a mutual person
Charges (Loans)
₹144.90 M
₹43.26 M
Charges Breakdown by Lending Institutions
- Others : 14.49 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Feb 2024 | Others | ₹9.54 Cr | Open |
| 29 Apr 2022 | Others | ₹4.95 Cr | Open |
| 30 Oct 2021 | Hdfc Bank Limited | ₹4.33 Cr | Satisfied |
How Many Employees Work at Saral Dx (Opc)?
Saral Dx (Opc) has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saral Dx (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saral Dx (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
